DCGI nod to Phase III trials of two-dose Zydus vax

New Delhi, Oct 5 (IANS) The Drugs Controller General of India (DCGI) has permitted Zydus Cadila to conduct Phase III trials of ZyCoV-D, the two-dose regimen of its needle-free Covid vaccine.The compa...

Become a proud member of 1947.com to access this content.